Andy W. Smith

Pharma Ventures Ltd. provides advisory services on life sciences transactions. It offers mergers and acquisitions, licensing, strategy and valuation, and expert services. The firm's industry coverage includes pharmaceuticals, biologics, drug delivery systems, diagnostics, medical devices, including telemedicine, medical software. The company is headquartered in Oxford, the United Kingdom.

AXA Investment Managers UK Ltd. (AXA IM-UK) is the UK-based investment subsidiary of AXA Framlington Group Ltd., itself a subsidiary of AXA SA (XP: CS, ADR: AXAHY) in France. The firm is headquartered in London and was founded in 1979. AXA IM-UK manages a diverse range of pooled funds and offers tailor-made investment products for liability management. They specialize in institutional pension fund management and individual retirement savings products.

AXA Framlington Investment Management Ltd. (AFIM), is the UK investment management subsidiary of AXA Investment Managers SA, itself a subsidiary of AXA SA (XP: CS) in France. Established in 1972, the firm is based in London. AXA Framlington is the trading name of AXA Framlington Investment Management Ltd. In addition to the London office, they also have specialized fund managers in Paris. AFIM is committed to becoming a leader in Responsible Investment and supporting sustainable financial markets. Their clients include investment trusts, pension funds, charities, institutions, unit trusts and PEP and ISA investors.

SV Health Investors LLP (SV Health Investors) is a venture capital firm founded in 1994 by Peter McPartland. The firm is headquartered in London.

Schroder Investment Management Ltd. (SIM) is the wholly-owned asset management subsidiary of Schroder International Holdings Ltd., ultimately held by Great Britain-based Schroders Plc (LSE: SDR, ADR: SHNWY). Established in 1985, SIM is headquartered in London and caters to a range of clients such as corporations, insurance firms, local and public authorities, charities, pension funds, high net-worth individuals and retail investors.